C2N Diagnostics: Funding, Investors & Team (Sep 2026)
The mission of C2N Diagnostics is bringing Clarity Through InnovationTM. It centres its therapeutic discovery work on mechanisms-based strategies to halt or prevent the progression of human neurological illnesses. Accurate, widely available, and reasonably priced blood tests are being developed for use in clinics to improve patient care and track the health of the brain. The PrecivityADTM blood test, which is its main commercial offering, uses mass spectrometry to evaluate numerous analytes in blood, including A-42, A-40, and various isoforms of apolipoprotein E. Although the test alone cannot diagnose Alzheimer's disease, which must be confirmed clinically by a medical professional, it is a crucial new tool for doctors to use in the evaluation process.
C2N Diagnostics has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in Feb 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
C2N Diagnostics Company Profile and Key Stats
Latest funding round on record: Feb 2023.
C2N Diagnostics Funding Rounds
C2N Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
C2N Diagnostics Funding Compared to Other Biotechnology Startups
C2N Diagnostics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like C2N Diagnostics in Biotechnology and Saint Louis
Companies Similar to C2N Diagnostics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
C2N Diagnostics Funding FAQs
What does C2N Diagnostics do?
The mission of C2N Diagnostics is bringing Clarity Through InnovationTM. It centres its therapeutic discovery work on mechanisms-based strategies to halt or prevent the progression of human neurological illnesses. Accurate, widely available, and reasonably priced blood tests are being developed for use in clinics to improve patient care and track the health of the brain. The PrecivityADTM blood test, which is its main commercial offering, uses mass spectrometry to evaluate numerous analytes in blood, including A-42, A-40, and various isoforms of apolipoprotein E. Although the test alone cannot diagnose Alzheimer's disease, which must be confirmed clinically by a medical professional, it is a crucial new tool for doctors to use in the evaluation process.
How much funding has C2N Diagnostics raised?
C2N Diagnostics has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in Feb 2023.
When did C2N Diagnostics last raise funding?
C2N Diagnostics' most recent funding round on record is an undisclosed round of $15.0M, announced in Feb 2023.
Who founded C2N Diagnostics?
FundedIQ lists Joel Braunstein (Founder) at C2N Diagnostics.
Where is C2N Diagnostics headquartered?
C2N Diagnostics is based in Saint Louis, Missouri, United States.
How many employees does C2N Diagnostics have?
C2N Diagnostics is in the 11-50 employee band.
How does C2N Diagnostics' funding compare to other Biotechnology startups?
C2N Diagnostics' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's C2N Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for C2N Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.